News
The European Commission approved up to €403 million ($472 million) in funding to support development of innovations in ...
After a tough few weeks for Sarepta Therapeutics Inc., the EMA dealt another blow on July 25, announcing it will not be approving the Duchenne muscular dystrophy gene therapy Elevidys (delandistrogene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback